137 related articles for article (PubMed ID: 36273375)
1. Comparison of the MOdified NARanjo Causality Scale (MONARCSi) for Individual Case Safety Reports vs. a Reference Standard.
Comfort SM; Donzanti B; Dorrell D; Dhar S; Eden C; Donaldson F
Drug Saf; 2022 Dec; 45(12):1529-1538. PubMed ID: 36273375
[TBL] [Abstract][Full Text] [Related]
2. MOdified NARanjo Causality Scale for ICSRs (MONARCSi): A Decision Support Tool for Safety Scientists.
Comfort S; Dorrell D; Meireis S; Fine J
Drug Saf; 2018 Nov; 41(11):1073-1085. PubMed ID: 29876835
[TBL] [Abstract][Full Text] [Related]
3. Leveraging Machine Learning to Facilitate Individual Case Causality Assessment of Adverse Drug Reactions.
Cherkas Y; Ide J; van Stekelenborg J
Drug Saf; 2022 May; 45(5):571-582. PubMed ID: 35579819
[TBL] [Abstract][Full Text] [Related]
4. Comparison of WHO-UMC and Naranjo Scales for Causality Assessment of Reported Adverse Drug Reactions.
Pandit S; Soni D; Krishnamurthy B; Belhekar MN
J Patient Saf; 2024 Jun; 20(4):236-239. PubMed ID: 38345209
[TBL] [Abstract][Full Text] [Related]
5. Comparison of three methods (consensual expert judgement, algorithmic and probabilistic approaches) of causality assessment of adverse drug reactions: an assessment using reports made to a French pharmacovigilance centre.
Théophile H; Arimone Y; Miremont-Salamé G; Moore N; Fourrier-Réglat A; Haramburu F; Bégaud B
Drug Saf; 2010 Nov; 33(11):1045-54. PubMed ID: 20925441
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different methods for causality assessment of adverse drug reactions.
Behera SK; Das S; Xavier AS; Velupula S; Sandhiya S
Int J Clin Pharm; 2018 Aug; 40(4):903-910. PubMed ID: 30051231
[TBL] [Abstract][Full Text] [Related]
7. Agreement of expert judgment in causality assessment of adverse drug reactions.
Arimone Y; Bégaud B; Miremont-Salamé G; Fourrier-Réglat A; Moore N; Molimard M; Haramburu F
Eur J Clin Pharmacol; 2005 May; 61(3):169-73. PubMed ID: 15827761
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury.
García-Cortés M; Lucena MI; Pachkoria K; Borraz Y; Hidalgo R; Andrade RJ;
Aliment Pharmacol Ther; 2008 May; 27(9):780-9. PubMed ID: 18284654
[TBL] [Abstract][Full Text] [Related]
9. Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool.
Gallagher RM; Kirkham JJ; Mason JR; Bird KA; Williamson PR; Nunn AJ; Turner MA; Smyth RL; Pirmohamed M
PLoS One; 2011; 6(12):e28096. PubMed ID: 22194808
[TBL] [Abstract][Full Text] [Related]
10. Consistency between causality assessments obtained with two scales and their agreement with clinical judgments in hepatotoxicity.
Miljkovic MM; Dobric S; Dragojevic-Simic V
Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):272-85. PubMed ID: 21351309
[TBL] [Abstract][Full Text] [Related]
11. Preliminary Results of a Novel Algorithmic Method Aiming to Support Initial Causality Assessment of Routine Pharmacovigilance Case Reports for Medication-Induced Liver Injury: The PV-RUCAM.
Scalfaro E; Streefkerk HJ; Merz M; Meier C; Lewis D
Drug Saf; 2017 Aug; 40(8):715-727. PubMed ID: 28508325
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three methods (an updated logistic probabilistic method, the Naranjo and Liverpool algorithms) for the evaluation of routine pharmacovigilance case reports using consensual expert judgement as reference.
Théophile H; André M; Miremont-Salamé G; Arimone Y; Bégaud B
Drug Saf; 2013 Oct; 36(10):1033-44. PubMed ID: 23828659
[TBL] [Abstract][Full Text] [Related]
13. Causality assessment of adverse drug reaction reports using an expert-defined Bayesian network.
Rodrigues PP; Ferreira-Santos D; Silva A; Polónia J; Ribeiro-Vaz I
Artif Intell Med; 2018 Sep; 91():12-22. PubMed ID: 30077492
[TBL] [Abstract][Full Text] [Related]
14. Can decisional algorithms replace global introspection in the individual causality assessment of spontaneously reported ADRs?
Macedo AF; Marques FB; Ribeiro CF
Drug Saf; 2006; 29(8):697-702. PubMed ID: 16872243
[TBL] [Abstract][Full Text] [Related]
15. Interrater agreement of two adverse drug reaction causality assessment methods: A randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the World Health Organization-Uppsala Monitoring Centre system.
Mouton JP; Mehta U; Rossiter DP; Maartens G; Cohen K
PLoS One; 2017; 12(2):e0172830. PubMed ID: 28235001
[TBL] [Abstract][Full Text] [Related]
16. A tailor-made approach for causality assessment for ADR reports on drugs and vaccines.
Oosterhuis I; Zweers P; Rümke H; Muller-Hansma A; van Puijenbroek EP
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):544-550. PubMed ID: 30168222
[TBL] [Abstract][Full Text] [Related]
17. Development of the Liverpool Adverse Drug Reaction Avoidability Assessment Tool.
Bracken LE; Nunn AJ; Kirkham JJ; Peak M; Arnott J; Smyth RL; Pirmohamed M; Turner MA
PLoS One; 2017; 12(1):e0169393. PubMed ID: 28046035
[TBL] [Abstract][Full Text] [Related]
18. Accuracy and reproducibility of two scales in causality assessment of unexpected hepatotoxicity.
Miljkovic MM; Dobric S; Dragojevic-Simic V
J Clin Pharm Ther; 2012 Apr; 37(2):196-203. PubMed ID: 21718339
[TBL] [Abstract][Full Text] [Related]
19. A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions.
Belhekar MN; Taur SR; Munshi RP
Indian J Pharmacol; 2014; 46(1):117-20. PubMed ID: 24550597
[TBL] [Abstract][Full Text] [Related]
20. Inter-expert agreement of seven criteria in causality assessment of adverse drug reactions.
Arimone Y; Miremont-Salamé G; Haramburu F; Molimard M; Moore N; Fourrier-Réglat A; Bégaud B
Br J Clin Pharmacol; 2007 Oct; 64(4):482-8. PubMed ID: 17711539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
